Video
Author(s):
Comprehensive discussion on the management of myelofibrosis, covering both monotherapy and combination therapy strategies.
Stay up to date on cancer updates, research and education
What Patients With Polycythemia Vera Should Know After ASCO 2025
FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis
Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis
Evolving Myelofibrosis Treatments Aims to Fill Unmet Needs